![]() |
|
|
Vol. 297, Issue 1, 224-229, April 2001
University of Connecticut, School of Pharmacy and Hartford
Hospital, Hartford, Connecticut (C.F., H.T., H.Z., L.Z.); and The
Chinese University of Hong Kong, School of Pharmacy, Faculty of
Medicine, Hong Kong, China (M.S.S.C.)
The purpose of the study was to test the hypothesis that diaspirin
cross-linked hemoglobin (DCLHb) can produce improved resuscitation during cardiac arrest. DCLHb, a derivative of human hemoglobin, has
previously been demonstrated to produce a vasopressor response that is
associated with increased blood flow to vital organs. In addition, it
is an oxygen carrier. These effects may be beneficial to extreme low
flow states, such as that during cardiac arrest and cardiopulmonary
resuscitation (CPR). Experimental cardiac arrest and CPR were carried
out in 32 anesthetized immature pigs. In each animal, ventricular
fibrillation was induced for 5 min, followed by 10 min of standard CPR
with a pneumatic device and room air ventilation. High (15 ml/kg) and
low (5 ml/kg) doses of DCLHb or equivalent volume of normal saline were
infused at the beginning of CPR in a random and blind manner. Cardiac
output, organ blood flow, aortic pressure, coronary perfusion pressure, blood gases, and lactate concentrations were obtained before and during
CPR. Following the 10-min CPR, the animals were defibrillated and the
return of spontaneous circulation (ROSC) determined. DCLHb treatment
achieved 75% ROSC compared with 25% in the saline group (p < 0.05). In addition, a better
(p < 0.05) myocardial O2 delivery, venous blood O2 content, and myocardial and cerebral
perfusion pressure were observed in the DCLHb group. DCLHb treatment
during cardiac arrest and CPR significantly improves ROSC. This is most likely related to its improvement in coronary perfusion and myocardial oxygen delivery.